Markets.News
back to home feed
Nu Skin reports Q4 2025 results with revenue at $370.32M ( ↓16.9% YoY), EPS at 29 cents (missed analyst expectations), stock sinks after weak quarter and soft outlook. Customer base down 10%, paid affiliates down 11%, sales leaders down 19%. Gross margin up to 70.7%, operating margin improves to 6.3%.
Nu Skin Enterprises Inc. (NYSE: NUS) released its fourth-quarter 2025 financial results and a 2026 outlook. The stock dropped post-announcement as the company fell short of analyst predictions. They reported a GAAP diluted EPS of 29 cents, missing the estimated 30 cents, and revenue of $370.32 million, below the expected $382.70 million. Compared to last year's $445.55 million, revenue decreased by 16.9%. Adjusted EPS was 29 cents, down from 38 cents the previous year. Gross margin rose to 70.7% from 62.7%, while operating margin improved to 6.3% from a negative 11.9%. The customer base dwindled by 10% to 748,796, paid affiliates decreased by 11% to 129,311, and sales leaders dropped by 19% to 30,045. The company noted the distribution of over 20,000 Prysm iO devices.